Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02708836 · ClinicalTrials.gov registry record · NA
Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique
A NA study of Limit Emergence Phenomena After General Anesthesia, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT02708836 is a NA study of Limit Emergence Phenomena After General Anesthesia that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 130 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02708836, a NA study of Limit Emergence Phenomena After General Anesthesia, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Emergence from general anesthesia with a laryngeal mask airway compared with an endotracheal tube has been shown to favorable with respect to limiting emergence phenomena such as coughing, straining, restlessness, and sympathetic stimulation leading to hypertension and tachycardia. Many anesthesiologists would prefer the use of an ETT to an LMA in cases in which higher ventilation pressures may be required, in those patients who are perceived to be high risk for reflux and pulmonary aspiration of gastric contents, as well as during cases that allow the anesthesiologist to have little accessibility the airway. The aim of this study is to investigate an airway management technique that would allow for the benefits of the ETT in terms of a secure airway for the duration of the surgical procedure as well the potential for less emergence phenomena seen when emerging with an LMA.
Conditions Studied
Interventions
- PROCEDURE Induction of anesthesia
- DEVICE Placement of LMA [Ambu (R) AuraGain (TM) disposable laryngeal mask]
- DEVICE Laryngoscopy and placement of ETT
- PROCEDURE Ventilation via the ETT
- PROCEDURE Removal of the ETT
Study Locations (1)
Pennsylvania
- Penn State Health - Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02708836
The ClinicalTrials.gov registry entry for NCT02708836 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Limit Emergence Phenomena After General Anesthesia appearing as the primary indexed condition, and to 5 interventions - of which Induction of anesthesia is the first listed.
NCT02708836 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02708836 about?
NCT02708836 is a clinical study titled "Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique". Emergence from general anesthesia with a laryngeal mask airway compared with an endotracheal tube has been shown to favorable with respect to limiting emergence phenomena such as coughing, straining, restlessness, and sympathetic stimulation leading to hypertension and tachycardia. Many anesthesiol...
What is the current status of trial NCT02708836?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2020-01-01. Estimated completion is 2026-06-01.
What conditions does trial NCT02708836 study?
This clinical trial studies the following conditions: Limit Emergence Phenomena After General Anesthesia.
What interventions are being tested in trial NCT02708836?
The interventions under investigation include: Induction of anesthesia (PROCEDURE), Placement of LMA [Ambu (R) AuraGain (TM) disposable laryngeal mask] (DEVICE), Laryngoscopy and placement of ETT (DEVICE), Ventilation via the ETT (PROCEDURE), Removal of the ETT (PROCEDURE).
Who is sponsoring clinical trial NCT02708836?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02708836 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.